Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CorMedix (CRMD) Long-Term Investments (2024 - 2025)

Historic Long-Term Investments for CorMedix (CRMD) over the last 2 years, with Q3 2025 value amounting to $22.9 million.

  • CorMedix's Long-Term Investments changed N/A to $22.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $22.9 million, marking a year-over-year change of. This contributed to the annual value of $105368.0 for FY2024, which is N/A changed from last year.
  • Per CorMedix's latest filing, its Long-Term Investments stood at $22.9 million for Q3 2025.
  • Over the past 5 years, CorMedix's Long-Term Investments peaked at $22.9 million during Q3 2025, and registered a low of $105368.0 during Q4 2024.